Andersen - OmicsDI

Show results for

Unknown (7220)
Transcriptomics (204)
Proteomics (198)
Genomics (131)
Metabolomics (10)
Models (4)
Genomic (2)
Multiomics (2)
Clinical (1)
Other (1)

Organisms

Homo sapiens (227)
Mus musculus (79)
Arabidopsis thaliana (15)
Myxococcus xanthus (9)
Drosophila melanogaster (8)
Myxococcus xanthus DK 1622 (8)
Bos taurus (7)
Saccharomyces cerevisiae (6)
Rattus norvegicus (6)
Aspergillus niger (4)
Aspergillus oryzae (3)
mixed sample (3)
Danio rerio (2)
Cavia porcellus (1)
Simiiformes sp. (1)
Bifidobacterium animalis subsp. lactis (1)
Canis lupus (1)
Dehalococcoides sp. ANAS2 (1)
Dehalococcoides (1)
environmental samples (1)
Lactobacillus acidophilus NCFM (1)
Pimephales promelas (1)
Dehalobacter restrictus (1)
Aspergillus oryzae RIB40 (1)
Macaca mulatta (1)
Listeria monocytogenes (1)
Oncorhynchus mykiss (1)
Caenorhabditis elegans (1)
Sus scrofa (1)
synthetic construct (1)

Organisms

Homo sapiens (38)
Mus musculus (29)
Myxococcus xanthus (4)
mixed sample (3)
Caenorhabditis elegans (2)
aerosol metagenome (1)
Austropeplea brazieri (1)
air metagenome (1)
human gut metagenome (1)
Drosophila melanogaster (1)

Repository

biostudies-arrayexpress (208)
pride (172)
ENA (93)
EGA (29)
MassIVE (17)
MetaboLights (9)
geo (7)
BioModels (4)
PAXDB (3)
dbGaP (2)
jPOST (2)
PeptideAtlas (2)
GNPS (1)
GPMDB (1)
PanoramaPublic (1)

Tissue

Cell culture (24)
Epithelial cell (15)
Brain (9)
Colon (8)
Skin (8)
Permanent cell line cell (7)
Blood (6)
Blood serum (6)
Liver (6)
Whole body (5)
Dendritic cell (4)
Follicular fluid (4)
Kidney (4)
Macrophage (4)
Blood plasma (3)
Colon sigmoideum (3)
Colonic mucosa (3)
Fibroblast (3)
Keratinocyte (3)
Melanocyte (3)
Neutrophil (3)
Plant cell (3)
T cell (3)
Venom (3)
Blood cell (2)
Blood platelet (2)
Bone marrow (2)
Heart (2)
Leaf (2)
Muscle (2)

Disease

Colon cancer (14)
Disease free (10)
Breast cancer (4)
Cholangiocarcinoma (4)
Primary sclerosing cholangitis (3)
Alzheimer's disease (2)
Female reproductive system (2)
Malignant neoplasm of ovary (2)
Prostate cancer (2)
Septic shock (2)
Andersen-Tawil syndrome (1)
Normal urothelium (1)
Tumor stage T2+ (1)
Bladder carcinoma (1)
Patients with LF syndrome and SOS of stage II active disease (1)
Diabetes Mellitus (1)
Not Available (1)
Acute leukemia (1)
B-cell adult acute lymphocytic leukemia (1)
Bacterial infectious disease (1)
Bacterial sepsis (1)
Barth syndrome (1)
Ciliopathy (1)
Colorectal cancer (1)
Complex partial epilepsy (1)
Cutaneous malignant melanoma 1 (1)
Eczema (1)
Huntington Disease (1)
Irritable bowel syndrome (1)
Liver disease (1)

Technology Type

Mass Spectrometry (172)
Shotgun proteomics (89)
Bottom-up proteomics (41)
Data-dependent acquisition (18)
Affinity purification coupled with mass spectrometry proteomics (13)
Data-independent acquisition (13)
Gel-based experiment (9)
Mass spectrometry (8)
Chemical cross-linking coupled with mass spectrometry proteomics (6)
Top-down proteomics (4)
DiaPASEF (2)
Glycoproteomics (2)
SWATH MS (2)
ION_TORRENT, Ion Torrent Proton (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 2500, ILLUMINA, Illumina MiSeq (1)
Mass spectrometry assay (1)
Affinity proteomics (1)
HDMSE (1)
MSE (1)
Mass spectrometry imaging (1)
SRM/MRM (1)

Instrument Platform

Q Exactive (9)
NextSeq 500 (5)
Liquid Chromatography MS - positive - reverse phase (4)
Illumina HiSeq 2000 (3)
Q Exactive HF (3)
Liquid Chromatography MS - negative - reverse phase (3)
Illumina HiSeq 1500 (2)
Illumina HiSeq 2500 (2)
Illumina NovaSeq 6000 (2)
Illumina HiSeq 3000 (2)
Orbitrap Fusion Lumos (2)
Gas Chromatography MS - (2)
MA900, Sony (1)
10x Chromium Controller (1)
Agilent DNA Microarray Scanner (1)
Illumina Genome Analyzer IIx (1)
Illumina NovaSeq X (1)
Instrument (1)
Agilent 1200 HPLC (1)
Agilent 1260, Velos Plus (1)
LTQ Orbitrap Elite (1)
Orbitrap Exploris 240 (1)
Thermo-Fisher LTQ XL (1)
Velos Plus (1)
Direct infusion MS - negative (1)
Direct infusion MS - positive (1)
LCMS-IT-TOF (Shimadzu) (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS – negative - reverse phase (1)

Publication Date

2012 (44)
2025 (36)
2021 (34)
2013 (29)
2024 (28)
2023 (26)
2015 (24)
2016 (23)
2014 (23)
2022 (20)
2010 (20)
2026 (17)
2011 (17)
2019 (14)
2009 (12)
2017 (12)
2020 (11)
2008 (11)
2007 (10)
2018 (9)
2004 (2)
2005 (1)
2006 (1)

UNIPROT ID/AC

35KD_MYCTU (3)
6PGL_MYCTU (3)
A85A_MYCTU (3)
A85B_MYCTU (3)
A85C_MYCTU (3)
ACCD_MYCTU (3)
ACDH_MYCTU (3)
ACDP_MYCTU (3)
ACEA_MYCTU (3)
ACG_MYCTU (3)
ACNA_MYCTU (3)
ACPM_MYCTU (3)
ACPS_MYCTU (3)
ACR_MYCTU (3)
ACYP_MYCTU (3)
ADD_MYCTU (3)
ADHB_MYCTU (3)
ADHC_MYCTU (3)
ADOK_MYCTU (3)
AHPC_MYCTU (3)
AHPD_MYCTU (3)
AHPE_MYCTU (3)
AK_MYCTU (3)
ALDH_MYCTU (3)
ALF_MYCTU (3)
ALR_MYCTU (3)
AMI4_MYCTU (3)
AMPA_MYCTU (3)
APA_MYCTU (3)
APEB_MYCTU (3)

CHEBI ID

CHEBI:17368 (3)
CHEBI:15428 (2)
CHEBI:15741 (2)
CHEBI:15756 (2)
CHEBI:15891 (2)
CHEBI:16040 (2)
CHEBI:16235 (2)
CHEBI:16449 (2)
CHEBI:16691 (2)
CHEBI:16811 (2)
CHEBI:16865 (2)
CHEBI:16919 (2)
CHEBI:17126 (2)
CHEBI:17319 (2)
CHEBI:17327 (2)
CHEBI:17351 (2)
CHEBI:17568 (2)
CHEBI:17750 (2)
CHEBI:17780 (2)
CHEBI:17992 (2)
CHEBI:18186 (2)
CHEBI:22470 (2)
CHEBI:22653 (2)
CHEBI:22660 (2)
CHEBI:24898 (2)
CHEBI:25017 (2)
CHEBI:26271 (2)
CHEBI:26986 (2)
CHEBI:27266 (2)
CHEBI:27570 (2)

Metabolite Name

Arachidic acid (2)
Aspartic acid (2)
Glycine (2)
Glycylproline (2)
Hypoxanthine (2)
Palmitic acid (2)
Phytol (2)
Stearic acid (2)
Succinate (2)
(+)-12-(2-Cyclopenten-1-yl)-2-dodecanone (1)
(+)-2,7-Dideoxypancratistatin (1)
(+)-Piperitone/d-Piperitone (1)
(+)-Prosopinine (1)
(+)-copalyl diphosphate (1)
(+)-trans-Carveol glucoside (1)
(+)TAN-67 (1)
(+/-)-(Z)-2-(5-Tetradecenyl)cyclobutanone (1)
(+/-)-Dihydrofarnesol (1)
(+/-)-Pelletierine (1)
(+/-)11(12)-EET Ethanolamide (1)
(-)-Solenopsin A (1)
(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C (1)
(13R,14R)-7-Labdene-13,14,15-triol (1)
(13R,14R)-8-Labdene-13,14,15-triol (1)
(1S,2R,4S)-(-)-Bornyl acetate (1)
(1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside (1)
(2'S)-Deoxymyxol 2'-(2,4-di-O-methyl-alpha-L-fucoside) (1)
(2'S)-Deoxymyxol 2'-alpha-L-fucoside (1)
(23S,24S)-17,23-Epoxy-24,29-dihydroxy-27-norlanost-8-ene-3,15-dione (1)
(24E)-15alpha-Acetoxy-3alpha-hydroxy-23-oxo-7,9(11),24-lanostatrien-26-oic acid (1)

First Public Date

2014 (37)
2017 (16)
2024 (8)
2026 (6)
2023 (5)
2013 (5)
2020 (3)
2016 (3)
2015 (3)
2025 (2)
2022 (2)
2018 (2)
2019 (1)

Modelling Approach

Ordinary differential equation model (2)
Constraint-based model (1)
Physiologically based pharmacokinetic model (1)

Study status

Recruiting (1)

Lab affiliation

MBG, Aarhus University, Denmark (4)
Max Planck Institute for Terrestrial Microbiology Karl-von-Frisch Str. 10 35043 Marburg Germany (4)
1School of Natural Sciences, Macquarie University, Sydney, NSW, Australia 2Institute for Glyco-core Research (iGCORE), Nagoya University, Aichi, Japan (3)
Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark (3)
EPFL (3)
Faculty of Chemistry, Biotechnology and Food Science Norwegian University of Life Sciences Post Office Box 5003 1432, Ås Norway (3)
Technical University of Munich, School of Medicine, Institute of Virology, 81675 Munich, Germany (3)
Clinical Chemistry, Department of Translational Medicine, Lund University, Skane University Hospital Malmö, 205 02 Malmö, Sweden. (2)
Department of Biochemistry, University of Utah (2)
Department of Chemistry & Bioscience Aalborg University Denmark (2)
Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia (2)
IMBA - Institute of Molecular Biotechnology Dr. Bohrgasse 3 1030 Vienna Austria (2)
Laboratory of Malaria and Vector Research, NIAID, NIH (2)
Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Denmark (2)
School of Natural Sciences, Macquarie University, Sydney, Australia (2)
The University of Melbourne (2)
1. School of Natural Sciences, Macquarie University, Sydney, NSW 2109, Australia 2. Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan (1)
1. School of Natural Sciences, Macquarie University, Sydney, New South Wales, Australia 2. Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan (1)
1.Precision Vaccines Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, MA, USA. 2. Department of Pediatrics, Harvard Medical School, Boston, MA, USA. (1)
1Instituto de Ciências Biomédicas, Departamento de Parasitologia, Universidade de São Paulo, USP, São Paulo, Brazil. (1)
Aalborg University (1)
Aarhus University, Department of Molecular Biology and Genetics (1)
Aarhus University. Denmark (1)
Anders H. Lund Professor, PhD Biotech Research and Innovation Centre University of Copenhagen Ole Maaloes Vej 5 DK-2200 N Copenhagen Denmark (1)
Associate Professor of Oncological Sciences Huntsman Cancer Institute at the University of Utah (1)
Associate professor at Macquarie University, Sydney, Australia Visiting professor at Institute for Glyco-core Research (iGCORE), Nagoya Univeristy, Aichi, Japan (1)
Biotech Research and Innovation Centre, University of Copenhagen, Ole Maaløes Vej 5, Copenhagen 2200, Denmark (1)
CDSS Bioanalytical Facility, Dept Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool (1)
CEO of GlyProVac LLC (1)
CIC bioGUNE Proteomics Platform, Bizkaia Tech. Park. Build 800 (1)

IsPrivate

False (4)

Model Flag

Non Kinetic (1)

Modification

Not available (2)
4x(2)H labeled dimethylated L-lysine (1)

Study type

Transcription profiling by array (144)
Methylation profiling by array (8)
Comparative genomic hybridization by array (7)
RNA-seq of coding RNA (7)
Other (6)
ChIP-seq (6)
RNA-seq of coding RNA from single cells (5)
ChIP-chip by tiling array (4)
RNA-seq of total RNA (3)
Transcription profiling by tiling array (2)
Genotyping by array (2)
Transcription profiling by RT-PCR (2)
RNA-seq of non coding RNA (2)
Baseline (1)
MicroRNA profiling by high-throughput sequencing (1)
Plant - High-throughput sequencing (1)
High-throughput sequencing (1)
RNAi profiling by array (1)
ChIP-chip by array (1)
CLIP-seq (1)
Proteomic profiling by array (1)
Methylation profiling by high throughput sequencing (1)
Observational (1)

Release Date

2022 (831)
2023 (730)
2025 (711)
2021 (703)
2024 (635)
2020 (578)
2019 (468)
2018 (431)
2017 (376)
2016 (337)
2015 (282)
2014 (240)
2012 (196)
2013 (195)
2011 (138)
2026 (129)
2010 (121)
2009 (95)
2008 (58)
2007 (55)
2006 (29)
2005 (23)
2003 (17)
2002 (13)
1998 (13)
2004 (11)
1999 (4)
2001 (3)
2000 (3)
1997 (2)

Location

Belgium (1)

Previous page
1 / 778
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 778
Next page

Sort by:

Relevance

Page size

The Andersen aerobic fitness test: reliability and validity in 10-year-old children.

Not available

S-EPMC4201545 | biostudies-literature

Poxyaibamberus Andersen & Dantas, gen. nov. (Diptera, Chironomidae, Orthocladiinae) from Brazil.

Not available

S-EPMC11193049 | biostudies-literature

Andersen-Tawil Syndrome: Genotype-phenotype correlation and longitudinal study CINCH 5301

PRJNA371671 | ENA

Characteristics of Andersen-Tawil Syndrome

Andersen-Tawil Syndrome (ATS) is a rare, genetic disorder that causes episodes of muscle weakness, potentially life-threatening changes in heart rhythm, and developmental abnormalities. Disease symptoms can vary, the cause of some ATS cases remains unknown, and no specific treatment has been iden...

phs001289 | dbGaP

Austropeplea brazieri strain:Andersen

Austropeplea brazieri mitochondrial genome sequencing and assembly

PRJNA1088272 | ENA

Enhancing bioaerosol sampling by Andersen impactors using mineral-oil-spread agar plate.

Not available

S-EPMC3584084 | biostudies-literature

Characterization of a novel, dominant negative KCNJ2 mutation associated with Andersen-Tawil syndrome.

Not available

S-EPMC3265798 | biostudies-literature

Factors Associated with Dental Service Use Based on the Andersen Model: A Systematic Review.

Not available